Summary Keywords imaging biomarkers, cerebrospinal fluid, -synuclein oligomers, phosphorylated -synuclein, extracellular vesicles, metabolomics, brain-derived neurotrophic factor, uric acid Citation Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV and Chakrabarti S (2021) Alpha-Synuclein as a Biomarker of Parkinsons Disease: Good, but Not Good Enough
Research results and third-party literature do not guarantee performance in any particular experiment
It is natively an orally-active compound
CMS lists Wegovy as an eligible GLP-1 drug for the Bridge when used to reduce excess body weight and maintain weight reduction
While research has primarily focused on men, women theoretically benefit from its fat-loss and recovery effects as well
Visit our GLP-1 category for current pack sizes and pricing.